Clinical Trial Detail

NCT ID NCT00828919
Title Continuing Access To AG- 013736 (A406) For Patients Previously Receiving AG 013736 In Clinical Trials
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

renal cell carcinoma

Therapies

Axitinib

Age Groups: adult

No variant requirements are available.